Want to see FR:ALHYF full AI Analyst Report?
Top Page
Lhyfe SA
(ALHYF)
Select Model
Select Model
Rating:41Neutral
Price Target:
€1.50
▼(-29.91% Downside)
Action:Reiterated
Date:08/06/26
The score is primarily held down by weak financial performance: worsening losses, persistent cash burn, and a materially more leveraged balance sheet with sharply reduced equity. Technicals add modest pressure as the stock trades below major moving averages with slightly negative momentum. Valuation provides limited offset because the company is loss-making (negative P/E) and no dividend yield is available.
Positive Factors
Revenue Growth
Revenue increased about 21% in 2025 versus 2024, showing that Lhyfe is converting its hydrogen offering into greater commercial activity. Continued top-line expansion can improve plant utilization and operating leverage over time, although profitability still depends on execution.
Negative Factors
Persistent Unprofitability
Deeply negative gross profit and a widening net loss show that current hydrogen activity is not yet producing an economically sustainable earnings profile. Without substantial improvement in pricing, utilization, or operating costs, growth could continue to increase losses rather than create durable profits.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Revenue increased about 21% in 2025 versus 2024, showing that Lhyfe is converting its hydrogen offering into greater commercial activity. Continued top-line expansion can improve plant utilization and operating leverage over time, although profitability still depends on execution.
Read all positive factors
Lhyfe SA (ALHYF) vs. iShares MSCI France ETF (EWQ)
Market Cap
€81.99M
Dividend YieldN/A
Average Volume (3M)26.89K
Price to Earnings (P/E)―
Beta (1Y)0.25
Revenue Growth91.61%
EPS Growth-74.56%
CountryFR
Employees188
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-1.06
Shares Outstanding48,265,903
10 Day Avg. Volume24,115
30 Day Avg. Volume26,890
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)6.30
Price to Sales (P/S)14.00
P/FCF Ratio-2.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.75
Revenue Forecast (FY)€16.10M
Lhyfe SA Business Overview & Revenue Model
Company Description
This renewable energy firm focuses on the full lifecycle of green hydrogen production plants, from their initial design and installation to their ongoing operation, throughout France. It currently manages 93 operational projects. The company serve...
How the Company Makes Money
Lhyfe primarily makes money by selling green hydrogen produced at its owned and operated electrolysis plants to customers under supply agreements. Its core revenue stream is the sale of hydrogen (typically priced per kilogram or via contracted off...
Lhyfe SA Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
32
Negative
Cash Flow
22
Negative
| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Lhyfe SA Technical Analysis
Negative
2.14
Price Trends
1.98
Negative
2.03
Negative
2.32
Negative
Market Momentum
-0.09
Positive
40.29
Neutral
35.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALHYF, the sentiment is Negative. The current price of 2.14 is above the 20-day moving average (MA) of 1.80, above the 50-day MA of 1.98, and below the 200-day MA of 2.32, indicating a bearish trend. The MACD of -0.09 indicates Positive momentum. The RSI at 40.29 is Neutral, neither overbought nor oversold. The STOCH value of 35.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:ALHYF.
Lhyfe SA Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | €1.12B | 8.46 | ― | 8.92% | -9.54% | -16.21% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | €145.42M | -4.44 | ― | ― | 253.75% | 39.39% | |
42 Neutral | €642.00M | -4.73 | -13.52% | ― | 19.27% | -192.48% | |
42 Neutral | €29.05M | -9.33 | -3.82% | ― | -91.03% | 47.04% | |
41 Neutral | €81.99M | -1.87 | ― | ― | 91.61% | -74.56% |
* Basic Materials Sector Average
FR:ALHYF
Lhyfe SA
1.73
-1.33
-43.33%
FR:VLTSA
Voltalia
4.73
-3.42
-41.95%
FR:HDF
Hydrogene de France
1.96
-2.04
-51.00%
FR:ALESE
Entech SA
10.02
1.38
15.93%
FR:ELEC
Electricite de Strasbourg SA
153.60
0.78
0.51%
FR:ALHAF
Haffner Energy SAS
0.73
0.50
210.59%
Lhyfe SA Corporate Events
Lhyfe Reports Share Capital and Voting Rights as It Expands European Green Hydrogen Footprint
Oct 5, 2026
Lhyfe SA, a European green hydrogen producer supplying low-carbon solutions for industry and mobility, reports its share capital and voting rights position as of 30 September 2026 in line with French market regulations. The company, listed on Euro...
Lhyfe and Perpetual Next Plan Major Green Hydrogen Supply for Delfzijl Biomethanol Plant
Oct 5, 2026
Lhyfe Delfzijl and Perpetual Next have signed a Memorandum of Understanding to explore a long-term supply of locally produced renewable hydrogen to Perpetual Next’s planned DeltaNor biomethanol plant in Delfzijl, within the Groningen chemica...
Lhyfe and H2APEX expand German renewable hydrogen partnership
Sep 16, 2026
Lhyfe and H2APEX have expanded their partnership to bolster Germany’s renewable hydrogen supply, reflecting the country’s role as one of Europe’s most dynamic hydrogen markets. Under the extended agreement, Lhyfe will deliver up ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.